Allogene Therapeutics Inc
(ALLO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -131,358 | -65,000 | -327,265 | -241,487 | -179,200 |
| Depreciation Amortization | 2,201 | 758 | 7,390 | 7,212 | 6,584 |
| Accounts payable and accrued liabilities | 6,690 | -118 | -7,502 | -7,200 | -3,233 |
| Other Working Capital | -24,036 | -5,650 | -21,307 | -16,235 | 3,063 |
| Other Operating Activity | 27,016 | 14,111 | 110,951 | 73,684 | 44,290 |
| Operating Cash Flow | $-119,487 | $-55,899 | $-237,733 | $-184,026 | $-128,496 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -8 | -1,516 | -1,335 | -1,323 |
| Purchase Of Investment | -123,739 | -81,131 | -438,629 | -369,927 | -170,514 |
| Sale Of Investment | 220,493 | 103,272 | 603,434 | 467,090 | 301,932 |
| Investing Cash Flow | $96,746 | $22,133 | $163,289 | $95,828 | $130,095 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 107,973 | 1,650 | 95,695 | 95,540 | 91,255 |
| Other Financing Activity | 2,280 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $110,253 | $1,650 | $95,695 | $95,540 | $91,255 |
| Beginning Cash Position | 93,447 | 93,447 | 72,196 | 72,196 | 72,196 |
| End Cash Position | 180,959 | 61,331 | 93,447 | 79,538 | 165,050 |
| Net Cash Flow | $87,512 | $-32,116 | $21,251 | $7,342 | $92,854 |
| Free Cash Flow | |||||
| Operating Cash Flow | -119,487 | -55,899 | -237,733 | -184,026 | -128,496 |
| Capital Expenditure | -8 | -8 | -1,516 | -1,335 | -1,323 |
| Free Cash Flow | -119,495 | -55,907 | -239,249 | -185,361 | -129,819 |